3,129
Views
2
CrossRef citations to date
0
Altmetric
Review Article

Psychedelics and the new behaviourism: considering the integration of third-wave behaviour therapies with psychedelic-assisted therapy

&
Pages 343-349 | Received 05 Feb 2018, Accepted 03 May 2018, Published online: 25 Sep 2018

References

  • Adamson, S., & Metzner, R. (1988). The nature of the MDMA experience and its role in healing, psychotherapy, and spiritual practice. Revision, 10(4), 59–72.
  • Angst, J., & Clayton, P. (1986). Premorbid personality of depressive, bipolar, and schizophrenic patients with special reference to suicidal issues. Comprehensive Psychiatry, 27, 511–532. doi:10.1016/0010-440x(86)90055-6
  • Badiner, A. H., & Grey, A. (Ed.). (2002). Zig Zag Zen: Buddhism and Psychedelics. San Francisco: Chronicle Books.
  • Barnhofer, T., Crane, C., Brennan, K., Duggan, D. S., Crane, R. S., Eames, C., … Williams, J.M.G. (2015). Mindfulness-Based Cognitive Therapy (MBCT) reduces the association between depressive symptoms and suicidal cognitions in patients with a history of suicidal depression. Journal of Consulting and Clinical Psychology, 83, 1013–1020. doi:10.1037/ccp0000027
  • Barrett, F. S., & Griffiths, R. R. (2017). Classic hallucinogens and mystical experiences: Phenomenology and neural correlates. In A. L. Halberstadt, F. X. Vollenweider, & D. E. Nichols (Eds.), Behavioral neurobiology of psychedelic drugs, Current topics in behavioral neuroscience. Thousand Oaks, CA: Sage.
  • Baum, W. M. (1995). Radical behaviorism and the concept of agency. Behaviorology, 3, 93–106.
  • Bernstein, A., Hadash, Y., Lichtash, Y., Tanay, G., Shepherd, K., & Fresco, D. M. (2015). Decentering and related constructs: A critical review and metacognitive processes model. Perspectives on Psychological Science: A Journal of the Association for Psychological Science, 10, 599–617. doi:10.1177/1745691615594577
  • Berzins, L. G., & Trestman, R. L. (2004). The development and implementation of dialectical behavior therapy in forensic settings. International Journal of Forensic Mental Health, 3, 93–103. doi:10.1080/14999013.2004.10471199
  • Bogenschutz, M. P., & Pommy, J. M. (2012). Therapeutic mechanisms of classic hallucinogens in the treatment of addictions: From indirect evidence to testable hypotheses. Drug Testing and Analysis, 4, 543–555. doi:10.1002/dta.1376
  • Bogenschutz, M. P., Forcehimes, A. A., Pommy, J. A., Wilcox, C. E., Barbosa, P., & Strassman, R. J. (2015). Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study. Journal of Psychopharmacology, 29, 289–299. doi:10.1177/0269881114565144
  • Bogenschutz, M. P., & Johnson, M. W. (2016). Classic hallucinogens in the treatment of addictions. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 64, 250–258.
  • Carhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C.M., Erritzoe, D., Kaelen, M., … Nutt, D. J. (2016). Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. Lancet Psychiatry, 3, 619–627. doi:10.1016/S2215-0366(16)30065-7
  • Chambers, R., Gullone, E., & Allen, N. B. (2009). Mindful emotion regulation: An integrative review. Clinical Psychology Review, 29, 560–572.
  • Clarke, K., Mayo-Wilson, E., Kenny, J., & Pilling, S. (2015). Can non-pharmacological interventions prevent relapse in adults who have recovered from depression? A systematic review and meta-analysis of randomised controlled trials. Clinical Psychology Review, 39, 58–70. doi:10.1016/j.cpr.2015.04.002
  • Crane, R. S., Brewer, J. A., Feldman, C., Kabat-Zinn, J., Santorelli, S. F., Williams, J. M. G., & Kuyken, W. (2017). What defines mindfulness-based programs? The warp and the weft. Psychiatry Publications and Presentations, 47, 990–999. doi:10.1017/S0033291716003317
  • Dass, R. (1971). Be here now. New York, NY: Crown Publishers.
  • Davis, D. M., & Hayes, J. A. (2011). What are the benefits of mindfulness? A practice review of psychotherapy-related research. Psychotherapy, 48, 198–208.
  • Dimeff, L. A., & Linehan, M. M. (2008). Dialectical behavior therapy for substance abusers. Addiction Science & Clinical Practice, 4, 39–47.
  • Dimidjian, S., Arch, J. J., Schneider, R. L., Desormeau, P., Felder, J. N., & Segal, Z. V. (2016). Considering meta-analysis, meaning, and metaphor: A systematic review and critical examination of “Third Wave” cognitive and behavioral therapies. Behavior Therapy, 47, 886–905. doi:10.1016/j.beth.2016.07.002
  • Fábregas, J. M., González, D., Fondevila, S., Cutchet, M., Fernández, X., Barbosa, P. C., … Bouso, J. C. (2010). Assessment of addiction severity among ritual users of ayahuasca. Drug and Alcohol Dependence, 111, 257–261. doi:10.1016/j.drugalcdep.2010.03.024
  • Fadiman, J. (2011). The psychedelic explorer's guide: safe, therapeutic, and sacred journeys. Rochester: Park Street Press.
  • Fung, K. (2015). Acceptance and commitment therapy: Western adoption of Buddhist tenets? Transcultural Psychiatry, 52, 561–576. doi:10.1177/1363461514537544
  • Gecht, J., Kessel, R., Forkmann, T., Gauggel, S., Drueke, B., Scherer, A., & Mainz, V. (2014). A mediation model of mindfulness and decentering: Sequential psychological constructs or one and the same? BMC Psychology, 2, 1–13. doi:10.1186/2050-7283-2-18
  • González, D. (2017, May 10). Long-Term Effects of Ayahuasca on Quality of Life & Well-Being [Video file]. Retrieved from https://www.youtube.com/watch?v=ZG-jH6k4pyc
  • Gray, N. S., Hill, C., McGliesh, A., Timmons, D., MacCulloch, M. J., & Snowden, R. J. (2003). Prediction of violence and self-harm in mentally disordered offenders: A prospective study of the efficacy of HCR-20, PCL-R, and psychiatric symptomatology. Journal of Consulting and Clinical Psychology, 71, 443–451.
  • Griffiths, R. R., Johnson, M. W., Richards, W. A., Richards, B. D., Jesse, R., MacLean, K. A., … Klinedinst, M. A. (2017). Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors. Journal of Psychopharmacology, 32, 49–69.
  • Halpern, J. H. (1996). The use of hallucinogens in the treatment of addiction. Addiction Research, 4, 177–189. doi:10.1016/j.pnpbp.2015.03.002
  • Hartogsohn, I. (2016). Set and setting, psychedelics and the placebo response: An extra-pharmacological perspective on psychopharmacology. Journal of Psychopharmacology, 30, 1259–1267.
  • Hayes, S. C., Luoma, J. B., Bond, F. W., Masuda, A., & Lillis, J. (2006). Acceptance and commitment therapy: Model, processes and outcomes. Behaviour Research and Therapy, 44, 1–25. doi:10.1016/j.brat.2005.06.006
  • Hayes, C. S. (2004). Acceptance and commitment therapy, relational frame theory, and the third wave of behavioral and cognitive therapies. Behaviour Therapy, 35, 639–665.
  • Hayes, S. C., Strosahl, K. D., & Wilson, K. G. (1999). Acceptance and commitment therapy: An experiential approach to behavior change. New York: Guilford Press.
  • Hendricks, P. S., Thorne, C. B., Clark, C. B., Coombs, D. W., & Johnson, M. W. (2015). Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States population. Journal of Psychopharmacology, 29, 280–288. doi:10.1177/0269881114565653
  • Hendricks, P., Crawford, M. S., Cropsey, K. L., Sweat, N. W., Walsh, Z., & Pavela, G. (2017). The relationship of classic psychedelic use with criminal behavior in the United States adult population. Journal of Psychopharmacology, 32, 37–48.
  • Johnson, M. W., Garcia-Romeu, A., Cosimano, M. P., & Griffiths, R. R. (2014). Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction. Journal of Psychopharmacology, 28, 983–992. doi:10.1177/0269881114548296
  • Kabat-Zinn, J. (2003). Mindfulness-based stress reduction (MBSR). Constructivism in the Human Sciences, 8, 73–107.
  • Kohlenberg, R. J., & Tsai, M. (1991). Functional Analytic Psychotherapy: A guide for creating intense and curative therapeutic relationships. New York: Plenum.
  • Kraehenmann, R., Preller, K. H., Scheidegger, M., Pokorny, T., Bosch, O. G., Seifritz, E., & Vollenweider, F. X. (2015). Psilocybin-induced decrease in amygdala reactivity correlates with enhanced positive mood in healthy volunteers. Biological Psychiatry, 78, 572–581. doi:10.1016/j.biopsych.2014.04.010
  • Kraehenmann, R., Schmidt, A., Friston, K., Preller, K. H., Seifritz, E., & Vollenweider, F. X. (2016). The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity. NeuroImage: Clinical, 11, 53–60. doi:10.1016/j.nicl.2015.08.009
  • Krebs, T. S., & Johansen, P.Ø. (2012). Lysergic acid diethylamide (LSD) for alcoholism: Meta-analysis of randomized controlled trials. Journal of Psychopharmacology, 26, 994–1002. doi:10.1177/0269881112439253
  • Kornfield, J. (2011). Bringing home the dharma: Awakening right where you are. Boston, MA: Shambhala.
  • Leary, T., Metzner, R., & Alpert, R. (1964). The psychedelic experience. New York: University Books.
  • Linehan, M. M., Armstrong, H. E., Suarez, A., Allmon, D., & Heard, H. L. (1991). Cognitive-behavioral treatment of chronically parasuicidal borderline patients. Archives of General Psychiatry, 48, 1060–1064.
  • Linehan, M. M. (1993). Cognitive-behavioral treatment of borderline personality disorder. New York: Guilford Press.
  • Linehan, M. M., Tutek, D. A., Heard, H. L., & Armstrong, H. E. (1994). Interpersonal outcome of Cognitive Behavioral Treatment for chronically suicidal borderline patients. American Journal of Psychiatry, 151, 1771–1776.
  • Linehan, M. M., Schmidt, H., Dimeff, L. A., Craft, J. C., Kanter, J., & Comtois, K. A. (1999). Dialectical behavior therapy for patients with borderline personality disorder and drug-dependence. The American Journal on Addictions, 8, 279–292. doi:10.1080/105504999305686
  • Linehan, M. M., Comtois, K. A., Murray, A. M., Brown, M. Z., Gallop, R. J., Heard, H. L., … Lindenboim, N. (2006). Two-Year randomized controlled trial and follow-up of dialectical behavior therapy vs. therapy by experts for suicidal behaviors and borderline personality disorder. Archives of General Psychiatry, 63, 757–766.
  • MacLean, K. A., Leoutsakos, J. M. S., Johnson, M. W., & Griffiths, R. R. (2012). Factor analysis of the mystical experience questionnaire: A study of experiences occasioned by the hallucinogen psilocybin. Journal of the Scientific Study of Religion, 51, 721–737.
  • Martell, C. R., Addis, M. E., & Jacobsen, N. S. (2001). Depression in context: Strategies for guided action. New York: W. W. Norton.
  • McMain, S. F., Links, P. S., Gnam, W. H., Guimond, T., Cardish, R. J., Korman, L., & Streiner, D. L. (2009). A randomized trial of dialectical behavior therapy versus general psychiatric management for borderline personality disorder. American Journal of Psychiatry, 166, 1365–1374. doi:10.1176/appi.ajp.2009.09010039
  • Öst, L. G. (2008). Efficacy of the third wave of behavioral therapies: a systematic review and meta-analysis. Behaviour Research and Therapy, 46, 296–321. doi:10.1016/j.brat.2007.12.005
  • Öst, L. G. (2014). The efficacy of acceptance and commitment therapy: An updated systematic review and meta-analysis. Behaviour Research and Therapy, 61, 105–121. doi:10.1016/j.brat.2014.07.018
  • Piet, J., & Hougaard, E. (2011). The effect of mindfulness-based cognitive therapy for prevention of relapse in recurrent major depressive disorder: A systematic review and meta-analysis. Clinical Psychology Review, 31, 1032–1040.
  • Richards, W. A. (2014). Here and now; Discovering the sacred with entheogens. Zygote, 49, 652–665. doi:10.1111/zygo.12108
  • Rucker, J. J., Jelen, L. A., Flynn, S., Frowde, K. D., & Young, A. H. (2016). Psychedelics in the treatment of unipolar mood disorders: A systematic review. Journal of Psychopharmacology, 30, 1220–1229.
  • Ruiz, F. J. (2012). Acceptance and commitment therapy versus traditional cognitive behavioral therapy: A systematic review and meta-analysis of current empirical evidence. International Journal of P.sychology & Psychological Therapy, 12, 333–357. doi:10.1016/j.beth.2011.07.004
  • Santos, R. G., Bouso, J. C., & Hallak, J. E. (2017). Ayahuasca, dimethyltryptamine, and psychosis: A systematic review of human studies. Therapeutic Advances in Psychopharmacology, 7, 141–157. doi:10.1177/2045125316689030
  • Segal, Z. V., Williams, M. G., & Teasdale, J. D. (2002). Mindfulness-Based Cognitive Therapy for Depression, First Edition: A New Approach to Preventing Relapse. New York: Guilford Press.
  • Shelton, D., Kesten, K., Zhang, W., & Trestman, R. (2011). Impact of a Dialectic Behavior Therapy - Corrections Modified (DBT-CM) upon behaviorally challenged incarcerated male adolescents. Journal of Child and Adolescent Psychiatric Nursing: Official Publication of the Association of Child and Adolescent Psychiatric Nurses, Inc, 24, 105–113. doi:10.1111/j.1744-6171.2011.00275.x
  • Soler, J., Elices, M., Franquesa, A., Barker, S., Friedlander, P., Feilding, A., … Riba, J. (2016). Exploring the therapeutic potential of Ayahuasca: Acute intake increases mindfulness-related capacities. Psychopharmacology, 233, 823–829. doi:10.1007/s00213-015-4162-0
  • Stotts, A. L., & Northrup, T. F. (2015). The promise of third-wave behavioral therapies in the treatment of substance use disorders. Current Opinion in Psychology, 2, 75–81. http://doi.org/10.1016/j.copsyc.2014.12.028
  • Swogger, M. T., Walsh, Z., Homaifar, B. Y., Caine, E., & Conner, K. R. (2012). Predicting self- and other-directed violence among discharged psychiatric patients: The roles of anger and psychopathic traits. Psychological Medicine, 42, 371–379. doi:10.1017/S0033291711001243
  • Tang, Y. Y., Tang, R., & Posner, M. I. (2016). Mindfulness meditation improves emotion regulation and reduces drug abuse. Drug Alcohol Dependence, 1, S13–S18.
  • Teasdale, J. D., Moore, R. G., Hayhurst, H., Pope, M., Williams, S., & Segal, Z. V. (2002). Metacognitive awareness and prevention of relapse in depression: Empirical evidence. Journal of Consulting and Clinical Psychology, 70, 278–287.
  • Thiessen, M. S., Walsh, Z., Bird, B., & Lafrance, A. (2018). Psychedelic use and intimate partner violence: The role of emotion regulation. Journal of Psychopharmacology. Advance online publication. doi:10.1177/0269881118771782
  • Thomas, G., Lucas, P., Capler, N., Tupper, K., & Martin, G. (2013). Ayahuasca-assisted therapy for addiction: Results from a preliminary observational study in Canada. Current Drug Abuse Reviews, 6, 30–42. doi:10.2174/15733998113099990003
  • Thoma, N., Pilecki, B., & McKay, D. (2015). Contemporary cognitive behaviour therapy: A review of theory, history, and evidence. Psychodynamic Psychotherapy, 43, 423–462.
  • Van Nuys, D. (Producer). (2007, October 15). Wise Counsel: An interview with Marsha Linehan, Ph.D. on Dialectical Behavior Therapy [Audio podcast]. Retrieved from https://www.jamhi.org/poc/view_doc.php?type=doc&id=13825
  • Walsh, Z., Hendricks, P. S., Smith, S., Kosson, D. S., Thiessen, M. S., Lucas, P., & Swogger, M. T. (2016). Hallucinogen use and intimate partner violence: Prospective evidence consistent with protective effects among men with histories of problematic substance use. Journal of Psychopharmacology, 30, 601–607.
  • Williams, J. M., Duggans, D. S., Crane, C., & Fennell, M. J. (2006). Mindfulness-based cognitive therapy for prevention of recurrence of suicidal behavior. Journal of Clinical Psychology, 62, 201–210.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.